Comparison

Molecules

1437732 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Piperidolate Chemicals Other Piperidolate is a tertiary amine antimuscarinic. It is similar to atropine. It is mainly used in the smooth muscle spasm of the gastrointestinal tract and inhibits intestinal cramp induced by acetylcholine in rats and dogs. DCC-DC60002-1g

DCChemicals
1 g Login
Compare
MK-­8719 Chemicals Other MK-8719 is a highly potent and selective OGA inhibitor (EC50 = 52.7 nM) which is a Potential Treatment for Tauopathies. MK-8719 showed excellent CNS penetration that has been advanced to first-in-human phase I clinical trials. DCC-DC60003-100mg

DCChemicals
100 mg Login
Compare
MK-­8719 Chemicals Other MK-8719 is a highly potent and selective OGA inhibitor (EC50 = 52.7 nM) which is a Potential Treatment for Tauopathies. MK-8719 showed excellent CNS penetration that has been advanced to first-in-human phase I clinical trials. DCC-DC60003-250mg

DCChemicals
250 mg Login
Compare
MK-­8719 Chemicals Other MK-8719 is a highly potent and selective OGA inhibitor (EC50 = 52.7 nM) which is a Potential Treatment for Tauopathies. MK-8719 showed excellent CNS penetration that has been advanced to first-in-human phase I clinical trials. DCC-DC60003-1g

DCChemicals
1 g Login
Compare
LY-­3475070 Chemicals Other LY-3475070 is a potent and selective CD73 Inhibitor with IC50 of 28 nM. LY3475070 Alone or in Combination With Pembrolizumab is now under trials for patients with Advanced Cancer. DCC-DC60008-100mg

DCChemicals
100 mg Login
Compare
LY-­3475070 Chemicals Other LY-3475070 is a potent and selective CD73 Inhibitor with IC50 of 28 nM. LY3475070 Alone or in Combination With Pembrolizumab is now under trials for patients with Advanced Cancer. DCC-DC60008-250mg

DCChemicals
250 mg Login
Compare
LY-­3475070 Chemicals Other LY-3475070 is a potent and selective CD73 Inhibitor with IC50 of 28 nM. LY3475070 Alone or in Combination With Pembrolizumab is now under trials for patients with Advanced Cancer. DCC-DC60008-1g

DCChemicals
1 g Login
Compare
ZAP-­180013 Chemicals Other ZAP-180013 is a Zap70 inhibitor, which inhibits interaction with ITAMs (immunoreceptor tyrosine-based activation motifs). DCC-DC60009-100mg

DCChemicals
100 mg Login
Compare
ZAP-­180013 Chemicals Other ZAP-180013 is a Zap70 inhibitor, which inhibits interaction with ITAMs (immunoreceptor tyrosine-based activation motifs). DCC-DC60009-250mg

DCChemicals
250 mg Login
Compare
ZAP-­180013 Chemicals Other ZAP-180013 is a Zap70 inhibitor, which inhibits interaction with ITAMs (immunoreceptor tyrosine-based activation motifs). DCC-DC60009-1g

DCChemicals
1 g Login
Compare
MK2-­IN-­3 Chemicals Other MK2 Inhibitor III is a potent, cell-permeable inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) and can be used for the treatment of rheumatoid arthritis. DCC-DC60011-100mg

DCChemicals
100 mg Login
Compare
MK2-­IN-­3 Chemicals Other MK2 Inhibitor III is a potent, cell-permeable inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) and can be used for the treatment of rheumatoid arthritis. DCC-DC60011-250mg

DCChemicals
250 mg Login
Compare
MK2-­IN-­3 Chemicals Other MK2 Inhibitor III is a potent, cell-permeable inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) and can be used for the treatment of rheumatoid arthritis. DCC-DC60011-1g

DCChemicals
1 g Login
Compare
D-­AP5 Chemicals Other DCC-DC60012-100mg

DCChemicals
100 mg Login
Compare
D-­AP5 Chemicals Other DCC-DC60012-250mg

DCChemicals
250 mg Login
Compare
D-­AP5 Chemicals Other DCC-DC60012-1g

DCChemicals
1 g Login
Compare
NK 252 Chemicals Other NK-252 is a Nrf2 activator. It acts by interacting with the Nrf2-binding site of Keap1 and downregulates the expression of fibrogenic genes. DCC-DC60016-100mg

DCChemicals
100 mg Login
Compare
NK 252 Chemicals Other NK-252 is a Nrf2 activator. It acts by interacting with the Nrf2-binding site of Keap1 and downregulates the expression of fibrogenic genes. DCC-DC60016-250mg

DCChemicals
250 mg Login
Compare
NK 252 Chemicals Other NK-252 is a Nrf2 activator. It acts by interacting with the Nrf2-binding site of Keap1 and downregulates the expression of fibrogenic genes. DCC-DC60016-1g

DCChemicals
1 g Login
Compare
ML251 Chemicals Other DCC-DC60028-100mg

DCChemicals
100 mg Login
Compare
93-­O17S Chemicals Other 93-O17S is an imidazole-based synthetic lipidoid for in vivo mRNA delivery. Lipid nanoparticles (LNPs) with 93-O17S promotes both the cross-presentation of tumor antigens and the intracellular delivery of cGAMP (STING agonist). DCC-DC53130-100mg

DCChemicals
100 mg Login
Compare
93-­O17S Chemicals Other 93-O17S is an imidazole-based synthetic lipidoid for in vivo mRNA delivery. Lipid nanoparticles (LNPs) with 93-O17S promotes both the cross-presentation of tumor antigens and the intracellular delivery of cGAMP (STING agonist). DCC-DC53130-25mg

DCChemicals
25 mg Login
Compare
C12-­200 Chemicals Other IV DCC-DC58046-100mg

DCChemicals
100 mg Login
Compare
C12-­200 Chemicals Other IV DCC-DC58046-25mg

DCChemicals
25 mg Login
Compare
C12-­200 Chemicals Other IV DCC-DC58046-50mg

DCChemicals
50 mg Login
Compare
Name Price
Piperidolate Login
Type Chemicals
Clone
Specific against Other
Appl. Piperidolate is a tertiary amine antimuscarinic. It is similar to atropine. It is mainly used in the smooth muscle spasm of the gastrointestinal tract and inhibits intestinal cramp induced by acetylcholine in rats and dogs.
Host
Item no.
Amount 1 g
Available
MK-­8719 Login
Type Chemicals
Clone
Specific against Other
Appl. MK-8719 is a highly potent and selective OGA inhibitor (EC50 = 52.7 nM) which is a Potential Treatment for Tauopathies. MK-8719 showed excellent CNS penetration that has been advanced to first-in-human phase I clinical trials.
Host
Item no.
Amount 100 mg
Available
MK-­8719 Login
Type Chemicals
Clone
Specific against Other
Appl. MK-8719 is a highly potent and selective OGA inhibitor (EC50 = 52.7 nM) which is a Potential Treatment for Tauopathies. MK-8719 showed excellent CNS penetration that has been advanced to first-in-human phase I clinical trials.
Host
Item no.
Amount 250 mg
Available
MK-­8719 Login
Type Chemicals
Clone
Specific against Other
Appl. MK-8719 is a highly potent and selective OGA inhibitor (EC50 = 52.7 nM) which is a Potential Treatment for Tauopathies. MK-8719 showed excellent CNS penetration that has been advanced to first-in-human phase I clinical trials.
Host
Item no.
Amount 1 g
Available
LY-­3475070 Login
Type Chemicals
Clone
Specific against Other
Appl. LY-3475070 is a potent and selective CD73 Inhibitor with IC50 of 28 nM. LY3475070 Alone or in Combination With Pembrolizumab is now under trials for patients with Advanced Cancer.
Host
Item no.
Amount 100 mg
Available
LY-­3475070 Login
Type Chemicals
Clone
Specific against Other
Appl. LY-3475070 is a potent and selective CD73 Inhibitor with IC50 of 28 nM. LY3475070 Alone or in Combination With Pembrolizumab is now under trials for patients with Advanced Cancer.
Host
Item no.
Amount 250 mg
Available
LY-­3475070 Login
Type Chemicals
Clone
Specific against Other
Appl. LY-3475070 is a potent and selective CD73 Inhibitor with IC50 of 28 nM. LY3475070 Alone or in Combination With Pembrolizumab is now under trials for patients with Advanced Cancer.
Host
Item no.
Amount 1 g
Available
ZAP-­180013 Login
Type Chemicals
Clone
Specific against Other
Appl. ZAP-180013 is a Zap70 inhibitor, which inhibits interaction with ITAMs (immunoreceptor tyrosine-based activation motifs).
Host
Item no.
Amount 100 mg
Available
ZAP-­180013 Login
Type Chemicals
Clone
Specific against Other
Appl. ZAP-180013 is a Zap70 inhibitor, which inhibits interaction with ITAMs (immunoreceptor tyrosine-based activation motifs).
Host
Item no.
Amount 250 mg
Available
ZAP-­180013 Login
Type Chemicals
Clone
Specific against Other
Appl. ZAP-180013 is a Zap70 inhibitor, which inhibits interaction with ITAMs (immunoreceptor tyrosine-based activation motifs).
Host
Item no.
Amount 1 g
Available
MK2-­IN-­3 Login
Type Chemicals
Clone
Specific against Other
Appl. MK2 Inhibitor III is a potent, cell-permeable inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) and can be used for the treatment of rheumatoid arthritis.
Host
Item no.
Amount 100 mg
Available
MK2-­IN-­3 Login
Type Chemicals
Clone
Specific against Other
Appl. MK2 Inhibitor III is a potent, cell-permeable inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) and can be used for the treatment of rheumatoid arthritis.
Host
Item no.
Amount 250 mg
Available
MK2-­IN-­3 Login
Type Chemicals
Clone
Specific against Other
Appl. MK2 Inhibitor III is a potent, cell-permeable inhibitor of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) and can be used for the treatment of rheumatoid arthritis.
Host
Item no.
Amount 1 g
Available
D-­AP5 Login
Type Chemicals
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
D-­AP5 Login
Type Chemicals
Clone
Specific against Other
Appl.
Host
Item no.
Amount 250 mg
Available
D-­AP5 Login
Type Chemicals
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 g
Available
NK 252 Login
Type Chemicals
Clone
Specific against Other
Appl. NK-252 is a Nrf2 activator. It acts by interacting with the Nrf2-binding site of Keap1 and downregulates the expression of fibrogenic genes.
Host
Item no.
Amount 100 mg
Available
NK 252 Login
Type Chemicals
Clone
Specific against Other
Appl. NK-252 is a Nrf2 activator. It acts by interacting with the Nrf2-binding site of Keap1 and downregulates the expression of fibrogenic genes.
Host
Item no.
Amount 250 mg
Available
NK 252 Login
Type Chemicals
Clone
Specific against Other
Appl. NK-252 is a Nrf2 activator. It acts by interacting with the Nrf2-binding site of Keap1 and downregulates the expression of fibrogenic genes.
Host
Item no.
Amount 1 g
Available
ML251 Login
Type Chemicals
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
93-­O17S Login
Type Chemicals
Clone
Specific against Other
Appl. 93-O17S is an imidazole-based synthetic lipidoid for in vivo mRNA delivery. Lipid nanoparticles (LNPs) with 93-O17S promotes both the cross-presentation of tumor antigens and the intracellular delivery of cGAMP (STING agonist).
Host
Item no.
Amount 100 mg
Available
93-­O17S Login
Type Chemicals
Clone
Specific against Other
Appl. 93-O17S is an imidazole-based synthetic lipidoid for in vivo mRNA delivery. Lipid nanoparticles (LNPs) with 93-O17S promotes both the cross-presentation of tumor antigens and the intracellular delivery of cGAMP (STING agonist).
Host
Item no.
Amount 25 mg
Available
C12-­200 Login
Type Chemicals
Clone
Specific against Other
Appl. IV
Host
Item no.
Amount 100 mg
Available
C12-­200 Login
Type Chemicals
Clone
Specific against Other
Appl. IV
Host
Item no.
Amount 25 mg
Available
C12-­200 Login
Type Chemicals
Clone
Specific against Other
Appl. IV
Host
Item no.
Amount 50 mg
Available

1437732 Item(s)

per page